Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print RSS Feed

Breaking News

Related Searches:
May 5, 2011
Early Development revenues were $224.0 million (+9%).   Read More »
May 5, 2011
SCM Pharma has secured a sterile filling and packaging project with Molteni Therapeutics, a specialty pharmaceutical company based in Italy, for a new drug substance in development for the topical treatment of infected skin lesions using the PhotoDynamic   Read More »
May 5, 2011
Claes Glassell has been appointed chief executive officer of CMC Biologics.  Read More »
May 4, 2011
Pfizer, Wyeth vet to take role over R&D and technology programs  Read More »
May 4, 2011
Beijing Second Pharmaceutical Co., Ltd. (BSPC) has received FDA approval of its ANDA 090752 for Amlodipine Besylate, a generic form of Pfizer’s Norvasc.   Read More »
May 4, 2011
Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million.  Read More »
May 4, 2011
Contract revenue in the quarter was $42.9 million, up 10%.  Read More »
May 4, 2011
Jeffrey S. Litwin, M.D. has been appointed president and chief executive officer of ERT and a member of the board.  Read More »
May 3, 2011
Akorn, Inc. has entered into an agreement to acquire Advanced Vision Research, Inc. (AVR), an OTC ophthalmic company, for $26 million in cash.   Read More »
May 3, 2011
Consolidated service revenue for the quarter was $227.0 million in Clinical Research Services (CRS), $34.1 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $40.3 million in Perceptive Informatics, Inc.   Read More »
May 3, 2011
Icagen and Pfizer have entered into a collaboration with the Yale School of Medicine to investigate potential new pain compounds identified by Icagen and Pfizer in their existing collaboration.   Read More »
May 3, 2011
Althea Technologies has entered into a commercial supply agreement with Biotest Pharmaceuticals under which Althea will fill commercial drug products to supply the U.S. market.   Read More »
May 3, 2011
King Pharma boost keeps revenues flat  Read More »
May 2, 2011
Teva has agreed to acquire Cephalon for approximately $6.8 billion in cash. The transaction is expected to close in 3Q011.  Read More »
May 2, 2011
Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. have signed a consent agreement with the U.S. Federal Trade Commission (FTC) outlining the conditions for Grifols’ acquisition of Talecris.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On